The overall effect across all treatments was − 0.27, indicating a trend toward significance despite considerable heterogeneity ( I 2 = 89.8%).
← all excerpts
Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis.
1
—
—